Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1007623.RAl-cXwDGyIenAOFlG-Elr9uob6HFsn2MQbJIFibI7L0g130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1007623.RAl-cXwDGyIenAOFlG-Elr9uob6HFsn2MQbJIFibI7L0g130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1007623.RAl-cXwDGyIenAOFlG-Elr9uob6HFsn2MQbJIFibI7L0g130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1007623.RAl-cXwDGyIenAOFlG-Elr9uob6HFsn2MQbJIFibI7L0g130_provenance.
- NP1007623.RAl-cXwDGyIenAOFlG-Elr9uob6HFsn2MQbJIFibI7L0g130_assertion description "[Topical application of a small molecular chemical inhibitor of ATX (S32826), which inhibited AH LysoPLD activity in vitro (by >90%), led to a dose-dependent and significant decrease of IOP in Dutch-Belted rabbits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1007623.RAl-cXwDGyIenAOFlG-Elr9uob6HFsn2MQbJIFibI7L0g130_provenance.
- NP1007623.RAl-cXwDGyIenAOFlG-Elr9uob6HFsn2MQbJIFibI7L0g130_assertion evidence source_evidence_literature NP1007623.RAl-cXwDGyIenAOFlG-Elr9uob6HFsn2MQbJIFibI7L0g130_provenance.
- NP1007623.RAl-cXwDGyIenAOFlG-Elr9uob6HFsn2MQbJIFibI7L0g130_assertion SIO_000772 22916143 NP1007623.RAl-cXwDGyIenAOFlG-Elr9uob6HFsn2MQbJIFibI7L0g130_provenance.
- NP1007623.RAl-cXwDGyIenAOFlG-Elr9uob6HFsn2MQbJIFibI7L0g130_assertion wasDerivedFrom befree-2016 NP1007623.RAl-cXwDGyIenAOFlG-Elr9uob6HFsn2MQbJIFibI7L0g130_provenance.
- NP1007623.RAl-cXwDGyIenAOFlG-Elr9uob6HFsn2MQbJIFibI7L0g130_assertion wasGeneratedBy ECO_0000203 NP1007623.RAl-cXwDGyIenAOFlG-Elr9uob6HFsn2MQbJIFibI7L0g130_provenance.
- befree-2016 importedOn "2016-02-19" NP1007623.RAl-cXwDGyIenAOFlG-Elr9uob6HFsn2MQbJIFibI7L0g130_provenance.